Literature DB >> 894341

Treatment of experimental spinal cord compression caused by extradural neoplasms.

Y Ushio, R Posner, J H Kim, W R Shapiro, J B Posner.   

Abstract

Epidural spinal cord compression was produced in rats by injection of Walker 256 carcinoma cell suspension anterior to the T-12 or T-13 vertebral body. The tumor grows through the intervertebral foramina to compress the spinal cord and produce paraplegia in 3 to 4 weeks. The effect of several treatments upon clinical signs was assessed. Dexamethasone caused a significant but transient improvement in neurological function. Radiation therapy likewise improved neurological function, and was more effective when given by a high-dose protracted course than when given either in a single dose or a low-dose protracted course. Laminectomy was not helpful in relieving neurological symptoms. Dimethyl sulfoxide did not relieve neurological symptoms. Cyclophosphamide was most effective in relieving neurological symptoms, and most of the animals that were treated with that drug when they were severely weak but still able to move their hind limbs recovered fully. Some animals that were totally paraplegic when treatment began recovered function after radiation therapy or cyclophosphamide treatment, but recovery was better if treatment was started when animals could still move their hind limbs. This animal model appears to be a useful way of studying the treatment of human spinal cord compression produced by epidural neoplasms.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 894341     DOI: 10.3171/jns.1977.47.3.0380

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  19 in total

1.  Managing spinal cord compression in small cell lung cancer.

Authors:  P Watson
Journal:  BMJ       Date:  1991-01-12

Review 2.  Back pain and epidural spinal cord compression.

Authors:  D W Bates; J B Reuler
Journal:  J Gen Intern Med       Date:  1988 Mar-Apr       Impact factor: 5.128

3.  Epidural compression from metastatic tumor with resultant paralysis.

Authors:  F L Ampil
Journal:  J Neurooncol       Date:  1989-07       Impact factor: 4.130

4.  Utility of surgery in the treatment of epidural vertebral metastases.

Authors:  A García-Picazo; P Capilla Ramírez; P Pulido Rivas; R Garcia de Sola
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

Review 5.  Metastasis to nervous system: spinal epidural and intramedullary metastases.

Authors:  Melike Mut; David Schiff; Mark E Shaffrey
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

6.  Establishing a rabbit spinal tumor model for nonvascular interventional therapy through CT-guided percutaneous puncture inoculation.

Authors:  L Chen; J Xiao; I-C Su; Y-W Wu; B Zhang; K-Y Ge; Y-C Chang; C Yang; C-F Ni
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-08       Impact factor: 3.825

Review 7.  Surgery for metastatic spinal disease.

Authors:  W C Welch; G B Jacobs
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 8.  Spinal cord compression in prostate cancer.

Authors:  J L Osborn; R H Getzenberg; D L Trump
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

9.  Treatment of spinal epidural neuroblastoma xenografts in rats using anti-GD2 monoclonal antibody 3F8.

Authors:  I Bergman; E Arbit; M Rosenblum; S M Larson; G Heller; N K Cheung
Journal:  J Neurooncol       Date:  1993-03       Impact factor: 4.130

10.  Complications in the management of metastatic spinal disease.

Authors:  Eilis Catherine Dunning; Joseph Simon Butler; Seamus Morris
Journal:  World J Orthop       Date:  2012-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.